Rhea-AI Summary
MindBio Therapeutics (OTCQB: MBQIF) is featured in a BioMedWire editorial highlighting its AI- and voice-analysis–based impairment detection platform. The company is developing real-time tools to assess drug and alcohol intoxication from short speech recordings.
This noninvasive approach targets limitations of traditional tests and aims at growing multibillion-dollar healthcare opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.58%
Tags
-
Rhea-AI Summary
MindBio Therapeutics (OTCQB: MBQIF) is developing an AI- and voice-based platform to predict drug and alcohol intoxication from short speech samples. The technology aims to provide real-time, noninvasive detection of impairment across multiple substances, targeting use cases in law enforcement, workplace safety, healthcare and public health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.04%
Tags
FAQ
What is the current stock price of MindBio Therapeutics (MBQIF)?
MindBio Therapeutics (MBQIF) last closed at $0.0451.
What is the market cap of MindBio Therapeutics (MBQIF)?
The market cap of MindBio Therapeutics (MBQIF) is approximately $436.5K.